ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
69,906.85
-0.32%
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs Yen
156.2805
0.02%
Brent Oil
82.19
-0.31%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Spruce Biosciences Inc (SPRB)

  7. Spruce Biosciences Inc (SPRB) ニュース

SPRB

Spruce Biosciences (SPRB)

Spruce Biosciences Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:SPRB
日付受信時刻ニュースソース見出しコード企業名
2024/05/1405 : 09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SPRBSpruce Biosciences Inc
2024/05/1405 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
2024/05/1405 : 01Business WireSpruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
2024/05/0205 : 05Business WireSpruce Biosciences to Participate in May Investor ConferencesNASDAQ:SPRBSpruce Biosciences Inc
2024/05/0105 : 05Business WireSpruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingNASDAQ:SPRBSpruce Biosciences Inc
2024/04/2305 : 05Business WireSpruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingNASDAQ:SPRBSpruce Biosciences Inc
2024/03/1405 : 08Business WireSpruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
2024/03/1405 : 01Business WireSpruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAHNASDAQ:SPRBSpruce Biosciences Inc
2024/03/0806 : 07Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SPRBSpruce Biosciences Inc
2024/02/0706 : 15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SPRBSpruce Biosciences Inc
2024/01/3106 : 05Business WireSpruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:SPRBSpruce Biosciences Inc
2024/01/2222 : 00Business WireSpruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal HyperplasiaNASDAQ:SPRBSpruce Biosciences Inc
2024/01/0822 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
2024/01/0522 : 00Business WireSpruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAHNASDAQ:SPRBSpruce Biosciences Inc
2024/01/0422 : 00Business WireSpruce Biosciences Provides Clinical Program Updates and Outlook for 2024NASDAQ:SPRBSpruce Biosciences Inc
2024/01/0406 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
2023/12/1910 : 17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
2023/12/1910 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
2023/11/2909 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
2023/11/1406 : 22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SPRBSpruce Biosciences Inc
2023/11/1406 : 09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
2023/11/1406 : 05Business WireSpruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
2023/11/0305 : 05Business WireSpruce Biosciences to Participate in the Jefferies London Healthcare ConferenceNASDAQ:SPRBSpruce Biosciences Inc
2023/10/1821 : 00Business WireSpruce Biosciences Completes Target Enrollment of CAHmelia-203 Study in Adult Classic Congenital Adrenal HyperplasiaNASDAQ:SPRBSpruce Biosciences Inc
2023/08/2905 : 00Business WireSpruce Biosciences to Participate in the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:SPRBSpruce Biosciences Inc
2023/08/1505 : 20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SPRBSpruce Biosciences Inc
2023/08/1505 : 12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
2023/08/1505 : 00Business WireSpruce Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
2023/07/0607 : 03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
2023/07/0607 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:SPRB

最近閲覧した銘柄

FX
USDJPY
US Dollar vs Yen
NASDAQ
MSFT
Microsoft
CCOM
US500
US 500
USOTC
ADDYY
Adidas (QX)
CCOM
SILVER
SILVER
PM
XAUUSD
Gold vs US Dollar
NYSE
VZ
Verizon Communications
NYSE
BAC
Bank of America
AMEX
XLF
Financial Select Sector
AMEX
XLV
Health Care Select Sector
FX
USDEUR
US Dollar vs Euro
NYSE
CVX
Chevron
NASDAQ
AMZN
Amazon.com
FX
USDGBP
US Dollar vs Sterling
NASDAQ
GOOGL
Alphabet
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有